News Releases
- Eli Lilly’s Announcement Regarding Oral GLP-1 Orforglipron
- Eli Lilly’s Announcement Regarding Oral GLP-1 Orforglipron (Statistically Significant Weight Reduction and a Safety Profile Consistent with Injectable GLP-1 Medicines in Phase III ATTAIN-1 in Adults with Obesity)
- Chugai Continues to be Listed for All ESG Indices Adopted by GPIF
Science and Technology
Science and Technology
Careers at Chugai
Careers at Chugai
Videos
CPR celebrates 10th Anniversary